Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 19, 2017 08:00 ET | Source: Graybug Vision, Inc.

Graybug Vision Initiates Phase 1/2 Trial of GB-102 for Wet Age-related Macular Degeneration

REDWOOD CITY, CA--(Marketwired - Sep 19, 2017) - Graybug Vision, Inc., a clinical-stage, venture-held pharmaceutical company committed to developing potentially transformative therapies for...
August 08, 2017 08:00 ET | Source: Graybug Vision, Inc.

Graybug Vision CEO to Participate in OIS@ASRS Conference

REDWOOD CITY, CA--(Marketwired - Aug 8, 2017) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
May 08, 2017 08:00 ET | Source: Graybug Vision, Inc.

Valerie Smith Joins Graybug Vision as VP, Global Clinical Development Operations

REDWOOD CITY, CA--(Marketwired - May 8, 2017) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
May 08, 2017 08:00 ET | Source: Graybug Vision, Inc.

Graybug Vision's Potential Once-Per-Year AMD Treatment Data Presented at ARVO 2017

REDWOOD CITY, CA--(Marketwired - May 8, 2017) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
April 04, 2017 08:01 ET | Source: Graybug Vision, Inc.

Graybug Vision to Present at the 16th Annual Needham Healthcare Conference on April 4

REDWOOD CITY, CA--(Marketwired - Apr 4, 2017) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
February 03, 2017 08:00 ET | Source: Graybug Vision, Inc.

Graybug Vision CEO Jeffrey Cleland Discusses Company's Prodrug Technology at Glaucoma 360 on February 3

REDWOOD CITY, CA--(Marketwired - Feb 3, 2017) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
January 03, 2017 08:00 ET | Source: Graybug Vision, Inc.

Graybug Vision Appoints Thomas S. Templeman, PhD, as Chief Operating Officer

REDWOOD CITY, CA--(Marketwired - Jan 3, 2017) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
November 21, 2016 08:00 ET | Source: Graybug Vision, Inc.

Graybug Vision to Present at the 28th Annual Piper Jaffray Healthcare Conference

REDWOOD CITY, CA--(Marketwired - Nov 21, 2016) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
June 21, 2016 08:00 ET | Source: Graybug Vision, Inc.

Graybug Vision Expands Executive Team With Appointments of Charles P. Semba, MD, and Ward M. Peterson, PhD

REDWOOD CITY, CA--(Marketwired - Jun 21, 2016) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
May 04, 2016 15:45 ET | Source: Graybug Vision, Inc.

Graybug Vision GB-102 Toxicology/PK Study Presented at ARVO 2016

REDWOOD CITY, CA--(Marketwired - May 4, 2016) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...